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Abstract 
 Siddha system of medicine is indigenous to India. The drug Karpoora Chindhamani 
Mathirai chosen from classic Siddha text is subjected to preclinical toxicity studies and for 
analgesic, anti-inflammatory and antipyretic effects in rats. These preclinical studies are 
performed to bring a strong evidence based support on the traditional medicine. Toxicity 
studies are performed as per OECD guidelines and Karpoora Chindhamani Mathirai at the 
dose of 2000 mg/kg/po did not exhibit any mortality in rats. Karpoora Chindhamani Mathirai 
exhibited significant anti inflammatory activity in both carrageenin induced hind paw and 
cotton pellet granuloma model in rats. The results are comparable to Diclofenac sodium 
(5gm/ kg/po). Karpoora Chindhamani Mathirai also exhibited significant antipyretic and 
analgesic activity . 
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Introduction: 
 Rheumatoid arthritis is an 
autoimmune disease that can cause chronic 
inflammation of the joints and other areas 
of the body (1). It can be correlated to 
Utiravathasuronitham / Mudakku vatham 
in Siddha literature (2). This is one of the 
vatha diseases mentioned by Sage Yugi. 
Rheumatoid arthritis is a chronic disease, 
characterized by periods of disease flares 
and remissions. 
 RA is a common chronic disease in 
developed countries (3). 8%-9% (70-80 
million approximately) of the adult 
population suffer from some of the other 
form of rheumatic disease and about 5%-
6% of the population has real joint or 
related disease (i.e, approximately 
50million population). Inflammation plays 
a major role in most chronic illness, 
including neurodegenerative, 
cardiovascular, pulmonary, metabolic, 
autoimmune and neoplastic disease. 
Inflammatory arthritides were also found 
in large number of patients (about 1%-5% 
i.e, 10million people with these disorders 
in India (4). Ayurvedic medicine can treat 
arthritis and need further scientific 
exploration. 
The WHO estimates that around 
80% of the world population in developing 
countries relies on traditional plant 
medicine for primary health care needs (5). 
Karpoora Chindhamani Mathirai, chosen 
from a classic siddha text Anuboga 
Vaidhya Navaneedham is expected to give 
best results for pain and joint inflammation 
in RA. In modern system of medicine 
DMRADs are prescribed for Rheumatoid 
arthritis and also steroids in many cases. 
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Karpoora Chindhamani Mathirai would 
be a better alternative to these drugs. 
 The rationale behind the selection 
of Karpoora Chindhamani Mathirai for 
this preclinical study is that most of the 
ingredients are used in inflammatory joint 
diseases and Croton tiglium, Linn., a 
drastic purgative brings the vatha humour 
to normal and the purgative action of 
Croton seeds will be countered my 
Nutmeg and Gum acacia. So, the medicine 
is expected to give cure to arthritis 
patients. 
 Rasakarpooram (Hydrargyrum 
subchloride–calomel), one of the major 
ingredient in the drug is used to cure 
various types of pain and rheumatism (6). 
The Siddha traditional preparation 
Chandamarutha chenduram in which 
calomel is a major ingredient is found to 
be very effective in treating post 
Chikungunya arthritis.(7).
 
The juice of the 
leaves of Aloe vera is applied to painful 
inflammation of the body
 
(8). The aqueous 
extract of Aloe vera inhibited 
prostaglandin t2 production from 
arachidonic acid. The aqueous extract has 
the capacity to inhibit cyclo-oxygenase 
activity. (9).Aloe vera is also found to be 
effective against adjuvant induced 
arthritis.(10). Croton tiglium, Linn. seeds 
are used in vatha diseases. For rheumatic 
conditions Croton oil with mustard oil will 
form a good liniment (11).
 
Myristica 
fragrans, Houtt is used as a rubefacient 
and is used as a good liniment for chronic 
rheumatism (12). Different solvent extract 
of Myristica fragrans, Houtt possess 
pharmacological properties like 
hypocholesteremic, anti-inflammatory, 
anti-diarrheal etc. The anti-inflammatory 
activity may be attributed to the active 
principle Myristicin.(13) Mace, the aril of 
Myristica fragrans, Houtt also possess 
anti-inflammatory activity (14 ). 
 
Materials and methods: 
 The raw drugs were purchased 
from authorized dealers from Tambaram 
and were authenticated by the Head, 
Department of Gunapadam 
(Pharmacology) of National Institute of 
Siddha, Tambaram sanatorium. The raw 
materials were purified as per the methods 
mentioned in classic Siddha text. The 
medicine was prepared as per the methods 
mentioned in Anuboga Vaidhya 
Navaneedham (part IV) Hakkeem Pa.Mu 
Abdulla Sayubu, 1
st
 edition, October 1995, 
Thamarai noolagam. The animal studies 
were carried out in C.L.Baid Metha 
College of Pharmacy, Thuraipakkam, 
Chennai. 
 
Preparation of the drug Karpoora 
Chindhamani Mathirai: 
Ingredients:  
 Purified Hydrargyrum subchloride 
-Rasakarpooram (Calomel) - 17 ½ G 
 Purified Myristica fragrans,Houtt 
(Nutmeg) – Sathikai - 17½G 
Purified Croton tiglium seeds -
Naervalam (Croton seeds)                             
- 35G                
 Aloe vera juice - Katralai – 
required quantity. 
 Acacia indica (gum acacia) powder 
- Karuvael pisin  - 3 ½ G. 
 
Step 1: Purification of raw drugs 
Purification of Calomel: 
 The poultice made of betel leaf 
(Piper betel) and pepper (Piper nigrum) 
each 8.7 grams is taken in an earthen pot 
and dissolved in 1.3 lit of water. Calomel 
35gms is tied with a cloth and immersed in 
the liquid from the cross bar and heated. 
When the water is reduced to ¾ of its 
volume calomel is taken out, washed with 
water and dried to get it in purified form 
(15). 
Purification of Nutmeg: 
 The outer cover is removed and 
then fried in ghee. 
Purification of Croton seeds: 
 Croton-35 G  
 Indian gooseberry fruit juice, 
Brinjal leaf juice, Cow dung each 20G is 
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taken in a vessel and its mouth is closed 
with a cloth. Croton seeds are placed over 
the cloth. It is burnt for 3 hours (1samam). 
Then its tip is removed and the seeds are 
dried in shade. This procedure is again 
repeated twice. Then it is fried in cow’s 
ghee (16). 
 
Purification of Aloe gel: 
 It is soaked in water for thee days 
and then used. 
Step 2: Method of preparation: 
Method: 
Croton seeds and Nutmeg are 
added to powdered Rasakarpooram and 
then  grounded. Then Aloe vera juice is 
added to the above mixture in small 
quantities as and when required. This 
mixture is grounded for 2 samam (6 hours 
). Finally powder of gum acacia is added 
and grounded. This paste is rolled into 
pills of 130 mg weight and dried in shade. 
These dried pills are preserved in a clean 
wide mouthed glass bottle. 
Dosage: 1 tablet (twice a day after food). 
Adjuvant: Ghee. 
Indications: This medicine is indicated for 
all types of fever, pain, arthritis and 
rheumatism (17). 
 
Animal studies:  
Preparation of drug for dosing: 
 Drug used for the study was 
suspended each time with 1% (w/v) 
solution of sodium Carboxy Methyl 
Cellulose before administration. 
 
Drugs and chemicals: 
 All fine chemicals used in this 
experiment were obtained from Sigma 
chemicals company, U.S.A. Other 
analytical grade chemicals were obtained 
from S.A fine chemicals Ltd., Mumbai. 
TAB vaccine was obtained from Serum 
institute, Pune. 
 
Experimental animals: 
 Colony inbred animal strains of 
Wistar rats of either sex weighing 200-
250G were used for the pharmacological 
and toxicological studies. 
 
Acute oral toxicity study: 
 Acute oral toxicity study was 
conducted as per the OECD guidelines 
(Organization of Economic Cooperation 
and Development) 423 (acute toxic class 
method). 
 Since this formulation is relatively 
non-toxic in clinical practice the highest 
dose of 2000mg/kg/po (as per the OECD 
guidelines “Unclassified”) was used in the 
acute toxicity study. 
 
Repeated oral toxicity study: 
 Group 1: Control animals received 
1% CMC, 10ml/kg/po for 21 days. 
            Group 2: Suspension of Karpoora 
Chindhamani Mathirai in CMC at the dose 
level of 12.5mg/kg/po for 21 days. 
 
Dose for rat: 
 Karpoora Chindhamani Mathirai-
12.5MG/KG/PO 
 At the end of 21days of treatment 
all the animals were sacrificed by over 
dosage of ether anaesthesia. Section of 
liver, kidney and heart were dissected out 
and kept in 10% formalin for 
histopathological studies. 
 
Biochemical studies: 
 Estimation of glucose, AST, ALT, 
ALP, Urea were done. 
 
Haematological studies: 
 Erythrocyte count, WBC, Hb, were 
studied. 
 
Analgesic, antipyretic and anti-
inflammatory activity of Karpoora 
Chindhamani Mathirai: 
Analgesic activity: 
Hot plate test: 
 The test was performed using 
Eddy’s hot plate maintained at a 
temperature of 55  1C.  The basal 
reaction time of all animals was recorded.  
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The animals which showed fore paw 
licking or jumping response within 6-8 
secs were selected for the study. 60 min 
after the administration of test and 
reference compounds, the animals in all 
the six groups were individually exposed 
to the hot plate maintained at 55C. The 
time taken in secs for fore paw licking or 
jumping was taken as reaction time. A cut 
off period of 15 secs is observed to avoid 
damage to the paws. Analgesic activity 
was recorded at hourly intervals of 2 hours 
after drug administration. 
 
Antipyretic activity:  
 Rats selected for the study 
were fasted overnight allowing water ad 
libitum. Initial rectal temperature was 
recorded using Hick’s clinical 
thermometer. Pyrexia was induced by 
subcutaneous injection of TAB vaccine 1 
ml/kg body weight.  Six hours later 
pyrexia was assessed and those animals 
that did not show a minimum rise of 1.5
o
C 
were rejected.  The animals thus found fit 
for the study was divided into 6 groups as 
described above and drugs were 
administered.  Pyrexia was recorded at 
hourly intervals for 3 hrs after drug 
administration.. 
 
Anti-inflammatory activity: 
 Anti-inflammatory activity of 
Karpoora Chindhamani Mathirai was 
evaluated in both acute and chronic 
models of inflammation. 
 
Acute model: 
 Carrageenin induced hind paw 
oedema ( Winter et al 1962). 
 
Chronic model: 
 Cotton pellet granuloma (Swingle 
and Svidem an et al;1972). 
 
Statistical analysis: 
 Students paired T-test is used for 
analyzing Hb, Markers of liver and kidney 
and antipyretic activity. One way 
ANOVA-Dunnett’s multiple comparison 
test is employed in assessing the analgesic 
and anti-inflammatory activity. 
 
Results and discussion: 
Acute oral toxicity study: 
 Karpoora Chindhamani Mathirai 
at the dose of 2000mg/kg/po did not 
exhibit any mortality in rats. As per OECD 
423 guidelines the dose is said to be 
“unclassified “under the toxicity scale. 
Here further study with higher doses was 
not executed. 
 
Repeated oral toxicity study for 21 days: 
 The test drug Karpoora 
Chindhamani Mathirai at the dose of 
12.5mg/kg/po when administered orally 
for 21 days in rats did not show toxicity in 
liver and renal functions.21 days repeated 
dosing of the drug did not exhibit change 
in serum glucose and cholesterol levels. 
 
Biochemical studies: 
 There was no significant change in 
glucose level, AST, ALT, ALP and Urea 
levels when compared to control. 
 
Haematological studies: 
 There was no significant change in 
Erythrocyte count, WBC and 
Haemoglobin count. 
 
Histopathological study: 
 Karpoora Chindhamani Mathirai 
at the dose of 12.5mg/kg/po daily 
administration for 21 days did not show 
evidence of pathological lesions in the 
tissues tested. 
 
Analgesic, Anti-inflammatory, 
Antipyretic studies: 
 Karpoora Chindhamani Mathirai 
exhibited significant anti-inflammatory 
activity in both carrageenin induced hind 
paw (acute inflammation model) and 
cotton pellet granuloma (chronic 
inflammation model) model of 
inflammation in rats. The results of the 
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present study was comparable to that of 
the standard NSAID Diclofenac sodium 
(5mg/kg/po). (Table 1, 2). 
Karpoora Chindhamani Mathirai at the 
dose of 12.5 mg/kg/po showed significant 
analgesic, antipyretic activity in rats. 
 
Table 1: 
Anti-inflammatory activity of Karpoora Chindhamani Mathirai in carrageenin induced 
hind paw edema in rats: 
 
Groups Paw volume(ml) by Mercury displacement at regular interval of time 
 0min 30min 60min 120min 240min 
Test 
Karpoora 
Chindhaman
i Mathirai 
0.901±0.034 1.0961±0.77 0.9781±0.04
4 
1.381±0.12** 01.22±0.017*
* 
Standard 
(Dic.sodium 
5mg/kg/po) 
0.883±0.63*
* 
0.996±0.067*
* 
1.02±0.064*
* 
0.926±0.041*
* 
0.896±0.026  
 
Table 2: 
Anti-inflammatory activity of Karpoora Chindhamani Mathirai in cotton pellet 
granuloma: 
 
Groups  Cotton pellet granuloma method 
                  Dry wt(mg) 
Control  115.87±15.42 
Test Karpoora Chindhamani 
Mathirai 
76.00±10.32** 
Standard (Dic.sodium 5mg/kg/po) 70.00±7.42** 
 
Discussion: 
 The Siddha formulation was tested 
for its reverse pharmacological and 
toxicological profiles in the experimental 
rats. The drug did not exhibit any mortality 
at the dose of 2000mg/kg/po and hence it 
is safe to be used in humans. The repeated 
oral toxicity also did not exhibit any 
change in haematological parameters. The 
test drug exhibited significant analgesic, 
antipyretic and anti-inflammatory activity 
in both acute and chronic experimental 
inflammatory condition in rats. The anti-
inflammatory activity was comparable to 
Diclofenac sodium (5mg/kg/po). Hence 
the drug will be clinically effective in 
inflammatory arthritis. The anti-
inflammatory activity can be attributed to 
the ingredients Rasakarpooram and Aloe 
vera. In Rheumatoid arthritis inflammation 
of major and minor joints is very common 
and so this drug can be tried for RA 
patients. The test drug showed maximum 
anti-inflammatory activity at the end of 4
th
 
hour after carrageenin challenge. The 
mechanism of anti-inflammatory activity 
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of the test drug may be attributed to its 
inhibitory activity on cyclooxygenase 
(COX) enzymes. 
 
Conclusion: 
 The drug Karpoora Chindhamani 
Mathirai in classic Siddha test exhibited 
no toxicity pre clinically. It also showed 
significant anti-inflammatory, analgesic 
and antipyretic activity. Hence the efficacy 
of this drug can be tested clinically in 
future. 
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